BIOTEST BIOTECH: The net profit for the year 2024 is 177 million yuan, a year-on-year increase of 65.74%

According to the Zhitong Finance APP, BIOTEST BIOTECH released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 561 million yuan, a year-on-year increase of 26.80%; the net profit attributable to the parent company's owners was 177 million yuan, a year-on-year increase of 65.74%; the net profit attributable to the parent company's owners after deducting non-recurring gains and losses was 127 million yuan, a year-on-year increase of 59.35%; basic earnings per share were 1.68 yuan/share

According to the Zhitong Finance APP, BIOTEST BIOTECH (688767.SH) released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 561 million yuan, a year-on-year increase of 26.80%; the net profit attributable to the parent company's owners was 177 million yuan, a year-on-year increase of 65.74%; the net profit attributable to the parent company's owners after deducting non-recurring gains and losses was 127 million yuan, a year-on-year increase of 59.35%; basic earnings per share were 1.68 yuan/share